GRAIL, Inc. (GRAL) Securities Class Action Filed Following NHS-Galleri Trial Failure and $2.2 Billion Market Cap Loss — HBSS

SAN FRANCISCO, July 7, 2026 /PRNewswire/ — On February 20, 2026, GRAIL, Inc. (NASDAQ: GRAL) shed over $2.2 billion of market capitalization after surprising investors with its NHS-Galleri Trial readout. The news caused huge investor losses and triggered a securities class action lawsuit… Source: prnewswire Country: United States

Pulse Clean Energy schließt zwei Energiespeicherprojekte in Großbritannien mit Unterstützung der Technologie-Leistungsversicherung von Ariel Green ab

Diese einzigartige Versicherung in Großbritannien bietet bis zu 13 Jahre Schutz und unterstützt damit die Projektfinanzierung sowie die langfristige betriebliche Flexibilität von Batterie-Energiespeicheranlagen LONDON, 8. Juli 2026 /PRNewswire/ — Pulse Clean Energy (Pulse), ein führendes… Source: prnewswire Country: United States

Concorde International Group Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency

SINGAPORE, July 08, 2026 (GLOBE NEWSWIRE) — Concorde International Group Ltd. (Nasdaq: YOOV) (the “Company”), an integrated provider of technology-enabled security solutions, today announced that the Company received a notification letter (the “Notification Letter”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”), dated July 1, 2026, notifying the Company that it … Read more

ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Roblox Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action – RBLX

NEW YORK, July 07, 2026 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Roblox Corporation (NYSE: RBLX) between October 30, 2025 and April 30, 2026, inclusive (the “Class Period”), of the important August 7, 2026 lead plaintiff deadline. Source: globenewswire Country: United States

TaiMed Biologics (4147) Receives TFDA Drug License Collection Notice for Trogarzo, Marking the Final Step Toward Commercial Launch in Taiwan

TAIPEI, July 07, 2026 (GLOBE NEWSWIRE) — TaiMed Biologics (TPEX: 4147) announced today that its HIV therapy Trogarzo (ibalizumab; English name: Trogarzo Injection; Chinese name: 佐加洛注射劑) has officially received a Drug License Collection Notice from the Taiwan Food and Drug Administration (TFDA). Its commercialization partner, Orient EuroPharma Co., Ltd. (“Orient EuroPharma”; TPEX: 4120), will complete … Read more

REMINDER: Nano-X Imaging Ltd. Investors With Significant Losses Must Act By August 11, 2026

NEW YORK, July 07, 2026 (GLOBE NEWSWIRE) — Kirby McInerney LLP reminds Nano-X Imaging Ltd. (“Nano-X” or the “Company”) (NASDAQ:NNOX) investors of the August 11, 2026 deadline to seek the role of lead plaintiff in a pending federal securities class action. Courts do not consider applications filed after this deadline. The lead plaintiff oversees the … Read more